NR2C2 and prostate cancer: NR2C2 is highly expressed in CD133+ prostate cancer stem/progenitor cells and promoted their invasion through enhancer of zeste homolog 2 signaling involving several metastasis-associated genes such as NOTCH1, SLUG, transforming growth factor β1, and matrix metalloproteinase 9 [30].